NEO
Neogenomics·NASDAQ
--
--(--)
--
--(--)
NEO fundamentals
Neogenomics (NEO) released its earnings on Feb 17, 2026: revenue was 190.17M (YoY +10.56%), beat estimates; EPS was 0.06 (YoY +50.00%), beat estimates.
Revenue / YoY
190.17M
+10.56%
EPS / YoY
0.06
+50.00%
Report date
Feb 17, 2026
NEO Earnings Call Summary for Q4,2025
- Revenue Growth: Q4 2025 revenue up 11% YoY to $190 million, with clinical revenue growing 16% YoY. Full-year revenue rose 10% to $727 million.
- NGS Momentum: NGS revenue grew 23% YoY in Q4, driven by higher-value tests and AUP expansion. PanTracer Pro and potential LBx approval could accelerate growth.
- MRD Expansion: RaDaR ST launched in February 2026 with 25 new sales reps targeting head and neck cancer. Additional MolDx submissions aim to double addressable market.
- Financial Health: 2026 guidance includes 10% revenue growth and 27%-31% EBITDA expansion, supported by gross margin improvements.
- Strategic Investments: $160 million in cash, with focus on R&D, sales force expansion, and LIMS integration for long-term efficiency gains.
Earnings
EPS
Revenue
Revenue & Expenses
NEO has released its 2025 Q4 earnings report, with revenue of 190.17M, reflecting a YoY change of 10.56%, and net profit of -9.88M, showing a YoY change of 35.52%. The Sankey diagram below clearly presents NEO's revenue sources and cost distribution.
Key Indicators
Neogenomics (NEO) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Neogenomics (NEO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Neogenomics (NEO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Neogenomics (NEO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Neogenomics (NEO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Neogenomics (NEO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Neogenomics do and what are its main business segments?What guidance did Neogenomics's management provide for the next earnings period?What is the market's earnings forecast for Neogenomics next quarter?What factors drove the changes in Neogenomics's revenue and profit?What is Neogenomics's gross profit margin?What were the key takeaways from Neogenomics’s earnings call?Did Neogenomics beat or miss consensus estimates last quarter?What were the key takeaways from Neogenomics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
